Trial Profile
A trial to compare skeletal related events in patients initiated on abiraterone acetate and enzalutamide
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Aug 2016
Price :
$35
*
At a glance
- Drugs Abiraterone acetate (Primary) ; Enzalutamide (Primary)
- Indications Prostate cancer
- Focus Adverse reactions
- 17 Aug 2016 New trial record